WCG Talks Trials

EXPLORE

Society & Culture

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/2e/83/1f/2e831f2c-a15b-de6d-1542-26671a9d7821/mza_1348759775792942798.jpg/600x600bb.jpg

WCG Talks Trials

WCG

86 episodes

1 week ago

In this episode of WCG Talks Trials, Sandy Smith, Sylvia Baedorf Kassis, and Dr. Donna Snyder discuss the critical role of health literacy in clinical research. They explore how clear communication can enhance patient understanding and engagement, the importance of a common language in research, and the introduction of the MRCT Center’s Clinical Research Glossary as a tool to facilitate better communication. The conversation emphasizes the need for consistent terminology and the integration o...

Show more...

Health & Fitness,

All content for WCG Talks Trials is the property of WCG and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

In this episode of WCG Talks Trials, Sandy Smith, Sylvia Baedorf Kassis, and Dr. Donna Snyder discuss the critical role of health literacy in clinical research. They explore how clear communication can enhance patient understanding and engagement, the importance of a common language in research, and the introduction of the MRCT Center’s Clinical Research Glossary as a tool to facilitate better communication. The conversation emphasizes the need for consistent terminology and the integration o...

Show more...

Health & Fitness,

Episodes (20/86)

WCG Talks Trials

Health Literacy in Action: The Impact of Plain Language Communication in Clinical Research

In this episode of WCG Talks Trials, Sandy Smith, Sylvia Baedorf Kassis, and Dr. Donna Snyder discuss the critical role of health literacy in clinical research. They explore how clear communication can enhance patient understanding and engagement, the importance of a common language in research, and the introduction of the MRCT Center’s Clinical Research Glossary as a tool to facilitate better communication. The conversation emphasizes the need for consistent terminology and the integration o...

3 weeks ago

28 minutes

WCG Talks Trials

Advancing Access: How SaaS is Transforming Clinical Trials

In this episode of WCG Talks Trials, Cristin MacDonald, Doug Mayer, and Tyler Bye discuss how Software as a Service (SaaS) solutions are democratizing the clinical trial landscape. Learn how SaaS platforms are enabling organizations of all sizes to leverage cutting-edge technology, improving collaboration, standardization, and data security throughout the clinical research process. The team shares the benefits of adopting SaaS, practical insights for successful implementation, and highlights ...

2 months ago

23 minutes

WCG Talks Trials

Advancing Imaging in Clinical Trials Using AI

In this episode of WCG Talks Trials, Silvio Galea, chief data and analytics officer, and Bryan Wayne, vice president of imaging operations, both of WCG, explore the critical role of imaging in clinical trials. Together, they break down industry acronyms, unpack the process of independent image review, and discuss how WCG is contributing to the validation and implementation of AI-driven radiology solutions. Listen in as they share behind-the-scenes insights into core lab operations, the signif...

2 months ago

21 minutes

WCG Talks Trials

Future-Ready Research: Optimizing Sites for Continued Success

In this episode of WCG Talks Trials, Sandy Smith, senior vice president, clinical solutions & strategic partnering, WCG, is joined by Tiffany Pierce, director, clinical trials core, Henry Ford Health System, to discuss resilience in clinical research. As the landscape of clinical trials faces evolving challenges, they explore how organizations and institutions, like Henry Ford Health, are addressing disruptions, uncertainties, and changes at the federal level. Learn about innovative strat...

4 months ago

20 minutes

WCG Talks Trials

Harnessing Generative AI in Clinical Research

Dive into the world of generative AI with Silvio Galea, chief data analytics officer, WCG, and Kyle Miller, lead data scientist, WCG. In this compelling episode of WCG Talks Trials, we explore how Generative AI can improve clinical research workflows from meticulous data entry to efficient data validation. Uncover the technology behind AI’s ability to assist in document updates, highlight transcription biases, and digitize complex data for predictive analytics. Understand the importance of hu...

5 months ago

23 minutes

WCG Talks Trials

AI in Clinical Trials: Unlocking the Potential

In this episode of WCG Talks Trials, join Silvio Galea, chief data and analytics officer, WCG, and Melissa Hutchens, vice president of research and benchmarking, WCG, as they discuss the transformative role of AI in clinical trials. Discover how generative AI and other AI technologies are enhancing the quality of clinical trials, reducing cycle times, and cutting costs. The episode covers the benefits, barriers, and concerns associated with AI, and explores its applications in drug discovery,...

7 months ago

27 minutes

WCG Talks Trials

Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials

Join us for "Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials" as we uncover the complexities of site management and the barriers to effective study start-ups. Discover the top issues impacting research sites and strategies to overcome them, including trial complexity, start-up hurdles, and long initiation timelines. Learn how effective communication, teamwork, and clear processes can drive success, and the importance of human connections and inclusivity in clin...

8 months ago

25 minutes

WCG Talks Trials

From Patient Care to Discovery: A Clinician's Journey into Research

Join us for a compelling episode of WCG Talks Trials where we take a look into the rewarding world of clinical trials and clinical development. In this episode, George Cokenakes, director of clinical services, review solutions, WCG, speaks with Dr. James Januzzi, a renowned cardiologist at Massachusetts General Hospital, and chief scientific officer at Baim Institute for Clinical Research. Dr. Januzzi shares his inspiring journey, highlighting the significance of clinical trial participation ...

10 months ago

19 minutes

WCG Talks Trials

Inside MAGI: Innovation, Education, and Industry Trends

In this episode of "WCG Talks Trials," host Geoffrey Schick, director of strategic site partnerships, WCG, is joined by fellow MAGI@home 2024 speakers Sandy Smith, Jess Thompson, and Wesley Warren. They share their unique perspectives and key takeaways from this year's virtual conference, including discussions on contract negotiations, the evolving role of advanced practice practitioners, and the collaborative panels featuring both site and sponsor/CRO insights. The episode also recaps the im...

11 months ago

29 minutes

WCG Talks Trials

Revolutionizing Clinical Research Through Collaboration and Innovation

In this episode of WCG Talks Trials, host Sandy Smith, senior vice president of clinical solutions and strategic partnering at WCG, dives into the highlights of the Florence Healthcare Research Revolution event. Sandy is joined by industry experts Andrea Bastek, vice president of innovation at Florence, and Lauren Sobocinski, senior vice president of strategic alliances at WCG, to discuss transformative insights from the event. Discover the latest trends shaping clinical research, including s...

12 months ago

28 minutes

WCG Talks Trials

Have a Safe Trip: Clinical and Patient Alignment in Research with Psychedelics

In this episode of WCG Talks Trials, host Kelly FitzGerald sits down with Dr. Currien MacDonald, Medical Chair Director at WCG, and Sara Reed, a participant in two psychedelic clinical trials, to explore the evolving landscape of psychedelics research. Dr. MacDonald shares his expertise on the growing acceptance of psychedelics in clinical settings, recent FDA updates, and the inner workings of ongoing trials. Later, Sara provides a firsthand account of her experiences as a trial participant,...

1 year ago

23 minutes

WCG Talks Trials

Breaking Barriers: Reasons to Expand Site Cancer Trial Portfolios

In this episode of WCG Talks Trials, Geoff Schick, director of strategic site partnerships, joins our host Sandy Smith, senior vice president of clinical solutions and strategic partnering, to discuss the expansion of research site cancer portfolios.

1 year ago

28 minutes

WCG Talks Trials

Patient Advocacy Advancing Breakthrough Science and Community Engagement

Join Desiree Underwood-Williams, director of project management organization at WCG and guest Steve Smith, CEO of SteveSmithPlans LLC and facilitator of the WCG Patient Forum, as they recap the latest Patient Forum Focus Session on breakthrough science and community engagement. Discussion highlights include:The impact of medical diagnoses on families with Sickle cell disease and melanoma.New research in cell and gene therapy that’s directly impacting Sickle cell disease and melanoma pat...

1 year ago

28 minutes

WCG Talks Trials

Guarding Research Integrity: The IRB's Essential Role

In this episode of WCG Talks Trials, we are joined by host Joanne Thomas, clinical reviewer and patient advocate at WCG, along with our guest Currien MacDonald, medical chair director at WCG. This episode covers the roles of IRB in ethical clinical research, frequently asked questions, and a general overview of the IRB’s role in clinical trials.

1 year ago

27 minutes

WCG Talks Trials

Addressing Challenges in Site Feasibility

This episode of WCG Talks Trials addresses site feasibility challenges impacting the clinical trials industry. Join Michelle Yu, associate director of clinical strategy at WCG, and our guest Trevor Cole, director of client delivery, site and strategic operations for WCG, as we discuss approaches to adopt innovative feasibility and site start-up solutions.Here are links to documents referenced in this episode:Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessm...

1 year ago

20 minutes

WCG Talks Trials

Ethical Review and AI in Clinical Trials

Join our Chief Analytics Officer Silvio Galea, along with Dr. Donna Snyder & Dr. Barbara Bierer to discuss opportunities on the ethical and regulatory challenges regarding artificial intelligence in clinical trials. The discussion is focused through the lens of the IRB review, and how a multi-stakeholder task force led by the Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and WCG will address the growing need for guidance in this rapidly evolving area of rese...

1 year ago

39 minutes

WCG Talks Trials

Addressing Measurement Challenges for PTSD Trials with Technology

In this episode of WCG Talks Trials, we are joined by WCG clinical science experts as they discuss traditional measurement challenges for PTSD trials and how the use of an electronic CAPS-5 scale is improving administration and scoring errors. Tune in as we discuss the CAPS-5 scale, the opportunities and benefits of using an electronic version to help standardize scale administration and scoring across clinical research, and the promising results to date.

1 year ago

21 minutes

WCG Talks Trials

What Is E-Consent? Interview with Erin Brower

1 year ago

9 minutes

WCG Talks Trials

Creating Partnerships: Aligning Vendor Support for Success in Clinical Research

In the most recent episode of WCG Talks Trials, we are joined by three industry experts, Amy Thue and Shelby Ward from WCG, and Russell Lampman from Merck to discuss the topic of optimizing vendor support, and ultimately the success, of clinical trials.Listen in as we dive into feedback and perspectives from both the sponsor and vendor side of the table—for valuable take-aways and insights into how vendor support is best aligned across all stakeholders.

1 year ago

20 minutes

WCG Talks Trials

WCG's IRB Policy Change: Harmonizing Consent (Part 2)

In Part 2 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses new FDA regulations for waiver of consent with Kelly Fitzgerald, PhD, WCG's IRB Executive Chair and VP IBC Affairs.

1 year ago

8 minutes